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Because of the sheer number of patients and
because of their location, the community practitioner
is in a position to deal with the vast majority of
problems that occur in hypertension. The trend in
hypertension therapy is toward individualizing the
work-up of the hypertensive patient, which with
many patients can be very simple.
When emphasizing aspects of practical office
care of the hypertensive, one of the first questions
that comes to mind is: what exactly is the blood
pressure?
There is not any one universally accepted defini
tion of hypertension. Until such a one is adopted, we
have put together a Medical College of Virginia defi
nition, using the opinions of several of us in the De
partment of Medicine (Fig I). We use the following
criteria:
I. A diastolic of 95 mm Hg. Anything greater
than this is hypertension.
2. The seated posture.
3. The diastolic pressure only; not the systolic
(for reasons which will be discussed later).
4. Disappearance of all sound (or phase V of
Korotkoff's sounds).
Thus, hypertension is defined as any measure
ment that is above 95 mm Hg diastolic, in the seated
posture. Sustained hypertension in our definition is
three such consecutive readings, or three out of four,
on an outpatient basis. This works out well in a prac
tical way, because the first reading can be the "screen
ing" blood pressure, the second one can be obtained
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during the first evaluation of the patient, and the
third one is taken when the lab work has come
back. and the physician is ready to make a de
cision about the course of treatment. Transient
hypertension is hypertension that comes and goes,
with normal blood pressures in between.
There are certain simple things that should be
done, short of long-term therapy, and these will some
times suffice. For instance, if a patient who is grossly
obese can be induced to lose 20% or 25% body
weight, often there will be a drop in the blood pres
sure. We have had very little success with this, unless
the patient can be induced to join a group where there
is high morale and a real motivation toward lowering
body weight. Such a group is far superior to drug
therapy. Another problem to be considered when
dealing with a new hypertensive is the "cultural salt
eater." There are some groups in the population that
eat very salty. rich foods as a family and cultural
tradition. Certain types of dishes extremely rich in
salt can increase the intake to 15 to 20 gm/day. This
can usually be discovered just by talking to the
patient. It is not necessary to collect a 24-hour speci
men for sodium excretion, though this would be a
way to document it. Some of these people will have a
mild drop in blood pressure when they are put on an
average salt diet. This has been one of the few in
stances where altering the salt content of the diet has
seemed useful to us in the management of uncompli
cated hypertension. Rarely, a patient with severe hy
pertension can benefit from salt restriction. Some
times, of course. it is necessary because of renal,
hepatic, or cardiac disease.
A few comments about contraceptive pills are in
order. There is an average increase in the blood pres159
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HYPERTENSION: Seated diastolic blood pressure greater than 95 mm Hg in either arm. Use phase V (disappearance of Korotkolfs
sounds). if IV and V differ by 4 rnm. record both.
SUSTAINED HYPERTENSION: Seated blood pressure greater than 95 mm Hg diastolic on three outpatient occasions out of four at
leasl one week apart. The pressures used may include the "screening" (or initial) pressure.

TRANSIENT HYPERTENSION: Any seated blood pressure greater than 95 mm Hg diastolic. People with transient hypertension
should be treated only if appropriate. or scheduled for return appointment for B.P. check in six months.
TREATABLE HYPERTENSION: That hypertension which in the judgment of the physician carries. untreated. a greater risk than
that of treatment. Near universal agreement now exists that seated diastolic B.P. grec1ter than 104 mm Hg (sustained) requires

treatment in males. perhaps females too: and that greater than 95 mm Hg diastolic (sustained) requires treatment if evidence of
cardiovascular damage is present (Grade II, III. or IV fundi. left ventricular .hypertrophy. evidence of cardiac decompensation.
evidence of coronary artery disease). Impaired renal function. proteinuria. or hematuria are not ordinarily the result of modest

elevation of blood pressure. Intermittent hypertension should probably also be treated if there if there is any detectable cardiovascular
damage reasonably attributable to the blood pressure or if documented acute rises seem dangerous.
Fig I-Definition of hypertension. as used al MCV/VCU.

sure of young women when they take these pills, even
in what we would call the normal population (I). The
order of this increase is about 14 mm Hg systolic and
8 to 9 mm Hg diastolic. It is sufficient to elevate the
blood pressure into what we would call hypertensioil
in a certain percentage of young women who take
these drugs. Such patients shouId be advised to use
other means of contraception. This is an unusual type
of hypertension: it builds up slowly in weeks to
months. and it lasts from four to six months after the
pill is discontinued. The physician cannot simply
check the patient in two to three weeks post-pill to see
if the high blood pressure has gone away. There is a
subtle biochemical change in the bloodstream, in
which the substrate for renin is actually increased.
Renin itself may rise at first, then later fall. Of course,
some patients are going to have to be treated. and
then have this treatment withdrawn after four to six
months to see if the problem has disappeared.
Another aspect in the care of the hypertensive is
the "treatment decision." This is the point at which
the physician has to decide whether or not to put the
patient on (usually) lifetime therapy. It is an impor
tant decision because of its implications for the
patient, having to do with self-image, the expense of
repeated office visits, and trouble for the doctor.
Therefore, a decision is best made with all available
data: several blood pressures, a history, physical ex
amination, and whatever lab work is appropriate for
that particular patient.
Figure 2 shows factors of importance in this deci
sion. We feel that a patient should be treated on the
basis of the blood pressure per se if the seated dia
stolic blood pressure is over I 04 mm Hg. This value is

from the Veterans Administration Cooperative Study
(2). We should recognize that their study involved
middle-aged men only. There were no females. The
evidence for treatment is not quite as strong for fe
males, but most authorities in this field feel that
women ought to be included in this group, and that
treatment is indicated (on blood pressure alone)
above 104 mm Hg diastolic pressure. This may
change as larger and larger populations are studied in
the future.
Below I 04 mm Hg but above 95 mm Hg, we feel
that an individualized decision is best. Various ways
of arriving at this have been advanced. Some physi-

TREATMENT DECISION
Worth �arcful consideration.
a. Risk of hypertensive complications.

b. Cost and bother of pills and oOice visits: adverse reactions.

2. Seated diastolic BP > 104 mm Hg (either sex), on three
successive. or three out of four. office visits.
J. Seated diastolic BP 95 to 104 mm HG
PLUS
a. Detectable CV damage.

OR
b. Risk factors: male sex. age under 50. black race. family
history. high cholesterol. diabetes. cigarenes. all readings
above 95.
Fig 2-Factors of importance in deciding whether or not the

patient needs treatment.
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cians even have a "point system" that adds up
"points" for the various factors. Such things consid
ered are age (young), sex (male), race (black), family
history (early occurrence of vascular diseases or hy
pertension), increased cholesterol, and cigarette
smoking. If cardiovascular damage can be detected
during evaluation of the patient, the likelihood of
further damage from hypertension is increased. Such
damage might show up as retinal findings, on the
electrocardiogram (left ventricular hypertrophy), and
so forth. In short, any evidence of cardiovascular
damage due to hypertension is thought to increase
the patient's risk for uncontrolled hypertension and
would be sufficient to put him in a "treatment" cate
gory, if the diastolic is above 95 mm Hg.
As to plasma renin, the postulate has been ad
vanced that "low renin hypertension" carries a low
risk. A few have even gone so far as to speculate that
perhaps these patients should not be treated at all.
We are not using renin for this purpose. The finding
of "low risk" associated with "low renin hyperten
sion" has been contradicted in a number of studies.
and the matter is, frankly, controversial (3).
The therapeutic aim of office management of
chronic hypertension is reduction of the blood pres
sure to normal. This tests the staying power of the
doctor and patient alike as usually it involves a life
time of therapy.
The problem of the "missing" patient (non
compliance) is a very difficult one and there is no
ideal answer. We send out a lot of letters (saying.
"where are you9") and an appointment card request
ing the patient to come back in. A one-to-one rela
tionship with the physician helps, and the interest the
doctor shows in treating the blood pressure, and his
interest in the patient, is most important. It has also
been shown that the one-to-one relationship need not
be with a physician (4). In large complex clinics,
where there is a shifting physician population, it has
been shown that a well-trained nurse (or paramedical
personnel) can take over this role, with the physician
then supervising the medical decisions to make sure
that these are appropriate. In most circumstances,
however, it is the physician who has to build this one
to-one relationship with the patient.
The patient ought to know the names of the
drugs being used for treatment, their chief side ef
fects, and the bottles ought to be labeled. This pro
cedure is useful for most patients, although there will
be some obvious exceptions. In terms of patient edu
cation, there are recent efforts to produce audiovisual
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or tape cassette aids for the patient. I have not yet
heard of one that I thought was good enough for
general use. Some are under development in the
American Heart Association and will be available
through local chapters in late 1975. A physician who
sees a large number of hypertensive patients may
want to tape a brief discussion of the condition for
the benefit of new hypertensives to avoid constant
repetition.
A number of drugs are available to treat high
blood pressure. Figure 3 is an attempt to subdivide
hypertensives into levels of blood pressure severity,
and to indicate the initial appropriate therapeutic
regimen. We have labeled "mildest hypertension" as
being in the range of 100 mm Hg diastolic. For this, a
thiazide diuretic is probably the best (5). The thiazide
diuretic dehydrates the patient very slightly, but the
blood volume and total body water come back to
normal after about two weeks. The patient does not
stay dehydrated, but his blood pressure stays down.
Fifty mg/day or twice a day or even 25 mg/day in a
few patients can suffice (hydrochlorothiazide). There
are some side effects that can be troublesome; hy
pokalemia, particularly in a patient who is taking
digitalis. A rise in the serum uric acid may occur. We
ignore this unless it gets very high or unless a patient
has a history of gout, in which case it is lowered with
allopurinol. Impairment of glucose tolerance occurs
in a certain number of patients. This may be amelio
rated by correction of hypokalemia. Thiazides do not
seem to cause diabetes de novo. Other diuretics have
MILDEST HYPERTENSION: Diastolic 100 mm Hg
Diuretic-thiazide is bcst-HCT 50 mg/day
or b.i.d.
MODERATELY HYPERTENSIVE: Diastolic 110 mm Hg
Reserpine 0.1 to 0.2 mg/day
Thiazide daily or b.i.d.
Add hydralazine 25 to 50 mg t.i.d., if needed
MODERATELY SEVERE: Diastolic 120 mm Hg
Methyldopa 250 mg b.i.d. and up
Thiazide daily or b.i.d.
Hydralazine 25 to 50 mg t.i.d., if needed
SEVERELY HYPERTENSIVE: Diastolic 130 mm Hg
Thiazide daily
Guanethidinc 25 mg (or much more) q.a.m.
(titrate individual dose by B.P. response)
(Later perhaps add hydralazine)
Fig )-Drugs useful in treatment of several "grades" of hyperten
sion.
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hypotensive effects. but they are not as strong as the
thiazide molecule. It does not matter which thiazide
is used. There are about 15 of them on the market: it
is a matter of dosage size. convenience.duration. and
other factors. We use hydrochlorothiazide at MCV.
For moderately hypertensive pat1ems (diastolic
in the range of I I 0). something else is usually used in
addition to the thiazide. The "something else" until
recently was reserpine. We have taken all of our
women hypertensives off reserpine. The reason is that
several large surveys done in ew York. and repeated
in London. have shown association between breast
cancer and reserpine therapy. This is a bombshell:
nobody expected it. Several people at MCV have
been over the data and say that the studies are well
done. We are taking it seriously. but the final resolu
tion of this problem awaits more data. The public
health hospitals and VA hospitals have not seen fit to
interfere with use of reserpine for their hypertensive
patients. but have contented themselves with sending
out a letter to all their physicians warning them about
this data. We use small doses of methyldopa instead
of the reserpine.
If something further is needed in addition to the
small dose of reserpine or a small dose of methyl
dopa. hydralazine is added. Hydralazine is a very
useful drug marketed under the name of Apresoline·•.
It is an old drug and has been around for a long time.
It fell into disuse because of worry about a lupus
erythematosus-like syndrome. which was quite
serious in some patients. Studies have shown. how
ever. that this will not occur if less than 200 mg/day is
given to an average-size patient. Our schedule works
out to a maximum dose of 150 mg/day. We use a lot
of hydralazine and we have seen very little difficulty
with it.
Moderately severe hypertensives. with diastolic
hypertension around 120. require methyldopa instead
of the reserpine. The dosage has to be titrated until
the desired response is achieved. About 3.5 gm/day
for the average-size patient is the largest effective dos
age in our experience. There have been some recom
mendations in the literature for a four-times-a-day
dosage. which is difficult for the patient to comply
with. We have come to the conclusion that a twice-a
day dosage is acceptable. which is important in terms
of compliance.
Severely hypertensive patients require our heavy
artillery. guanethidine, marketed as l smelin® (6).
This is an annoying and troublesome drug to deal
with. It interferes with sympathetic transmission in

the periphery and, therefore, interferes with postural
reflexes. We have a lot of patients walking the tight
rope between symptomatic postural hypotension
and control of their blood pressure with guanethi
dine. The drug takes several days to achieve its full
effect. once given, and it takes several days to ease off
once the dosage is decreased. It interferes with sexual
function in males: this can be a limiting factor. Some
men simply will not take the drug once they have had
this experience. A physician can sometimes get by
with less guanethidine and addition of a somewhat
similar drug that does not have the same side effects,
such as methyldopa. The MCV schedule says 25 mg
"or much more." The dose of guanethidine is the
level achieved in the individual patient after titration.
The dosage can be as much as 250 to 300 mg/day in a
few patients. Hydralazine can be added to this pro
gram also and will sometimes help in the control
without adding additional symptoms. Gastrointes
tinal distress is a problem with guanethidine. It does
not seem to produce any irreversible reaction in the
G.I. tract, but it can certainly produce a symptomatic
diarrhea that is very annoying. Lomotil® (diphenoxy
late) is useful for this. Guanethidine can also cause
exercise hypotension, a problem with laborers. We
try to get by. if we can. without using large doses of
guanethidine. There are. however. some patients who
require it.
Another drug just recently on the market is cloni
dine or Catapres-'
' . This drug has a mechanism of
action similar to methyldopa, probably a central
(brain) action that "turns down" the sympathetic sys
tem so that it is less active. Clonidine is used similarly
to methyldopa. We have not used much of it at MCV
because of a pronounced "overshoot" of blood pres
sure when it is stopped.
A word about drug combinations. It is obvioui
that more than one drug is often used. Drug com
binations are useful and important because they are
cheaper and because they simplify compliance to ther
apy. They may present some difficulties, however. A
well-known triple combination contains reserpine 0.1
mg. hydralazine 25 mg, and hydrochlorothiazide 15
mg. If this is given twice a day. an appropriate dose of
reserpine is being given but not enough hydralazine
or enough hydrochlorothiazide. If the frequency is
increased to three times a day. the dosage contains a
reasonable amount of hydralazine. but still not quite
enough thiazide and already too much reserpine. If
the frequency is increased yet to six times a day.
entirely too much reserpine is being given. Most
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patients will feel badly if they are taking that much
reserpine. The hydralazine and hydrochlorothiazide
are acceptable. The best way to handle combinations
is to start the patient on individual components, see
what he needs, and then look up the combinations
to see if you can switch him to something that is
cheaper and involves one less pill, in which case it is
worth doing.
There are a few patients who are not going to
respond to standard therapy. A vasodilator of suf
ficient power would decrease the blood pressure by
increasing the size of peripheral arteries, and allowing
the blood to circulate faster (7). When this is done, an
increase in cardiac output occurs with an annoying
heavy palpitation and heavy heart beat. In some in
stances. angina pectoris occurs where it did not exist
before. (This can be a side effect to hydralazine, for
instance, in a patient with coronary disease). Such a
vasodilator may also cause systemic edema, in some
instances even heart failure, and weight gain. These
undesirable effects can be blocked. Propranolol. (ln
deral") will block the tachycardia. A diuretic (thiaz
ide or furosemide) will prevent the weight gain and
edema. This is called "triple therapy." Vasodilators
that are more powerful than hydralazine will come on
the market within a year or so. allowing better use of
this triple therapy. The name of one is minoxidil.
Propranolol must be used cautiously as it does inter
fere with stroke volume, and it presents a significant
danger to people with heart disease, particularly
heart disease that has been of sufficient magnitude to
have ever caused heart failure. This is regarded as a
contraindication under most circumstances. Asthma
is also a contraindication. We give propranolol in
such a manner as to not drive the heart rate down too
low. We like to have the heart rate remain at 60 or
above, seated.

In summary, in office management of hyperten
sion, patient education is very important; patient mo
tivation and a strong doctor-patient relationship are
needed. The interest and enthusiasm of the physician
in treating blood pressure will often be the determin
ing factor in whether or not the patient complies.
Very simple therapy suffices for most patients. Con
trol is possible even in most severe cases, but with
these, considerable individualization will be needed
and frequent office visits.
Figun:s 1 and 2 arc reproduced with permission from the

Virginia Medical Mo111hly ( 101:942-947, 1974).
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